Active ingredientSurlorianCat. No. P-S137-001CAS 1467605-57-7Family · Pharmaceutical analytical standards
Surlorian
An experimental molecule of the Rycal class, a benzothiazepine that stabilises the RyR1 ryanodine receptor of muscle, reducing abnormal calcium leak: it has been studied for RYR1-related myopathies and Duchenne muscular dystrophy. This family brings together the active ingredient and other impurities.
Did you know?The Rycal class was discovered by Andrew R. Marks of Columbia University; in the first human study, carried out between 2019 and 2021, the molecule was well tolerated.
Go to the active ingredient →Active ingredientSurlorianCat. No. P-S137-001CAS 1467605-57-7
ImpuritySurlorian Impurity 1Cat. No. P-S137-002CAS 927871-76-9No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.